Back to top

A long-term, observational study tracking the nature of HIV progression and treatment response among women who acquired HIV while taking part in an MTN “parent study” testing different antiretroviral (ARV)-based products for the prevention of HIV.  MTN-015 will help researchers understand the impact of using these products on the natural history and clinical course of HIV and on the prevalence and patterns of HIV drug resistance over time.  Results from MTN-015 have been published as the parent studies have been completed and reported results.  MTN-015 results from participants in the HOPE study are anticipated in late 2019 or early 2020.

 

MTN-015 Q&A

15-August-2016

 

See Also

MTN-015 Study Protocol

 

MTN-015 Study Page